Thanks for the great post as usual Mason.
I’d started giving consideration to whether RACE would use a similar approach for PD-1 to how they structured their Proteasome inhibitor cancer synergy/heart safety announcement by singling out Amgen’s Carfilzomib for possible partnership opportunities based on their relatively near-term patent expiry of 2025.
JDP provided a good list of RACE’s recent patent application listing about half a dozen PD-1 inhibitors that are likely being tested in their in-vitro and in-vivo preclinical trials. I was doing a quick check on patent expiry to see if one of them was approaching that patent cliff sooner than other and therefore may be a more obvious target beyond the all-important results of the preclinical trials themselves.
I came across this article about Merck, which had some interesting comments about Merck pursing co-formulations, which is exactly what we shareholders would ideally want to see is a Zantrene-Pembrolizumab (Keytruda) combination. So, it was good to see Merck already entertaining those combination options to extend patent expiry dates. Also, there is a good reference in their possible M&A targets including targeted oncology & mRNA companies.
Can’t wait to see the results from RACE this quarter!
https://www.biospace.com/article/merck-s-davis-scouring-for-deals-in-preparation-for-keytruda-patent-cliff-/
- Forums
- ASX - By Stock
- Unlisted Options Transactions
Thanks for the great post as usual Mason. I’d started giving...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.46 |
Change
0.055(3.91%) |
Mkt cap ! $239.3M |
Open | High | Low | Value | Volume |
$1.45 | $1.46 | $1.45 | $232 | 160 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 313 | $1.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 2896 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 313 | 1.425 |
1 | 491 | 1.420 |
1 | 235 | 1.415 |
5 | 13751 | 1.405 |
7 | 21645 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.445 | 2896 | 2 |
1.450 | 341 | 1 |
1.455 | 660 | 1 |
1.460 | 754 | 1 |
1.475 | 755 | 1 |
Last trade - 10.15am 07/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
RAC (ASX) Chart |